Ventricular tachycardia ablation in nonischemic cardiomyopathy

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Daniel Jorge Nascimento Matos

Hospital de Santa Cruz, Carnaxide (Portugal)

38 More presentations in this session

Presentation thumbnail

A territory-wide study of arrhythmogenic right ventricular cardiomyopathy patients from Hong Kong

Mr I. Lakhani (Hong Kong, CN)

Abstract Slides

Presentation thumbnail

Arrhythmias caused by mutations in SCN5A in children

Miss E. Polyakova (Moscow, RU)

Abstract Slides

Presentation thumbnail

Real-world evaluation of follow up strategies after implantable cardiac-defibrillator therapies in patients with ventricular tachycardia (REFINE-VT)

Doctor P. Tran (Coventry, GB)

Abstract Slides

Presentation thumbnail

Sex differences in incidence of out-of-hospital cardiac arrest across ethnic and socioeconomic groups: a population-based cohort study in the Netherlands

Ms R. Bolijn (Amsterdam, NL)

Abstract Slides

Presentation thumbnail

Socioeconomic data predict adverse cardiovascular outcomes

Professor J. Kostis (New Brunswick, US)

Abstract Slides

Access the full session

Session thumbnail

Ventricular arrhythmias and sudden cardiac death e-posters

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

Congress Presentation

Case 1 - first choice treatment: antiarrhythmic drugs or catheter ablation?

Congress Presentation

Ablation is alternative to ICD therapy in post-myocardial infarction patients with haemodynamically well-tolerated sustained monomorphic VT and LVEF>40%: con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources